Characteristic | Age < 50 years, n = 65 | Age ≥ 50 years, n = 60 | Odds ratio (95% CI) | P value |
---|---|---|---|---|
Polypharmacy | 17 (26.5%) | 42 (23.3%) | 6.58 (3.01–14.39) | < 0.001 |
Antihypertensive medication | 2 (3.1%) | 21 (35%) | 11.37 (2.75–46.46) | < 0.001 |
Antihyperglycemic medication | 2 (3.1%) | 17 (28.3%) | 9.2 (2.22–38.19) | < 0.001 |
NSAIDs | 4 (6.2%) | 14 (23.3%) | 3.79 (1.32–10.88) | 0.009 |
Anticonvulsants/anxiolytics | 4 (6.2%) | 14 (23.3%) | 3.79 (1.32–10.88) | 0.009 |
Current sildenafil use | 6 (9.2%) | 14 (23.3%) | 2.52 (1.03–6.15) | 0.032 |
Antacid | 4 (6.2%) | 12 (20%) | 3.25 (1.1–9.53) | 0.03 |
Antihyperglycemic agents | 1 (1.5%) | 11 (18.3%) | 11.91 (1.58–89.54) | 0.001 |
Vitamins/minerals | 1 (1.5%) | 11 (18.3%) | 11.91 (1.58–89.54) | 0.002 |
Antidepressants | 4 (6.4%) | 4 (6.2%) | 1.08 (0.28–4.14) | 1.0 |
Antibiotics | 11 (16.9%) | 3 (5%) | 0.29 (0.08–0.98) | 0.047 |
Diuretics | 1 (1.5%) | 2 (3.3%) | 2.16 (0.2–23.28) | 0.60 |
Food supplements | 0 (0%) | 3 (5%) | 0.10 |